Canine and murine models of osteosarcoma

Jessica Beck1, Ling Ren1, Shan Huang1

  • 1National Cancer Institute, Bethesda, MD.

Veterinary Pathology
|March 28, 2022
PubMed

Insights

Osteosarcoma (OS) research needs better animal models. This review explores mouse and pet dog models, highlighting their complementary roles in advancing human OS understanding and treatment.

Area of Science:

  • Veterinary Medicine
  • Oncology
  • Comparative Pathology

Background:

  • Osteosarcoma (OS) is the most common pediatric bone cancer.
  • Current therapies have not improved patient outcomes since the 1980s.
  • Metastasis remains the primary cause of mortality in OS patients.

Purpose of the Study:

  • To review current animal models for osteosarcoma research.
  • To emphasize the value of both mouse and canine models.
  • To highlight the potential of comparative oncology in OS studies.

Main Methods:

  • Review of existing literature on osteosarcoma animal models.
  • Discussion of xenograft, PDX, and transgenic mouse models.
  • Exploration of naturally occurring canine osteosarcoma cases.

Main Results:

  • Mouse models (xenograft, PDX, transgenic) offer insights into OS biology.
  • Naturally occurring canine OS provides a valuable translational model.
  • Both models are critical for advancing OS research.

Conclusions:

  • Continued development and use of diverse animal models are essential for osteosarcoma research.
  • Canine osteosarcoma models complement mouse models, offering unique translational opportunities.
  • Comparative oncology approaches can accelerate the development of novel OS therapies.